These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10697171

  • 1. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair.
    Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K.
    Plast Reconstr Surg; 2000 Feb; 105(2):638-47. PubMed ID: 10697171
    [Abstract] [Full Text] [Related]

  • 2. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC, Feng L, Pollock AS, Lovett DH.
    Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
    [Abstract] [Full Text] [Related]

  • 3. Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue-derived inhibitor of metalloproteinase ratio.
    Dang CM, Beanes SR, Lee H, Zhang X, Soo C, Ting K.
    Plast Reconstr Surg; 2003 Jun; 111(7):2273-85. PubMed ID: 12794470
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing.
    Vaalamo M, Leivo T, Saarialho-Kere U.
    Hum Pathol; 1999 Jul; 30(7):795-802. PubMed ID: 10414498
    [Abstract] [Full Text] [Related]

  • 5. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
    Liu K, Olofsson JI, Wahlberg P, Ny T.
    Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
    [Abstract] [Full Text] [Related]

  • 6. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 7. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct 02; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 8. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2004 Aug 02; 84(15):1288-93. PubMed ID: 15387968
    [Abstract] [Full Text] [Related]

  • 9. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
    Ma DH, Chen JK, Kim WS, Hao YX, Wu HC, Tsai RJ, Hwang DG, Zhang F.
    Ophthalmic Res; 2001 Aug 02; 33(6):353-62. PubMed ID: 11721189
    [Abstract] [Full Text] [Related]

  • 10. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P.
    J Cell Biol; 1997 Apr 07; 137(1):67-77. PubMed ID: 9105037
    [Abstract] [Full Text] [Related]

  • 11. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
    Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, Stetler-Stevenson WG.
    Oral Dis; 2000 Nov 07; 6(6):376-82. PubMed ID: 11355270
    [Abstract] [Full Text] [Related]

  • 12. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
    Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G.
    Histochem Cell Biol; 2000 Jun 07; 113(6):443-53. PubMed ID: 10933221
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 07; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
    Nagel H, Laskawi R, Wahlers A, Hemmerlein B.
    Histopathology; 2004 Mar 07; 44(3):222-31. PubMed ID: 14987225
    [Abstract] [Full Text] [Related]

  • 15. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
    Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.
    BMC Cancer; 2009 Jan 14; 9():20. PubMed ID: 19144199
    [Abstract] [Full Text] [Related]

  • 16. [Expression of matrix metalloproteinases and their inhibitors in fetal skin and their biological significance].
    Li WJ, Chen W, Fu XB, Zhu RZ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May 14; 18(5):303-6. PubMed ID: 16701000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A, Laue S, Rost AK, Scherbaum WA, Aust G.
    Thyroid; 1998 Mar 14; 8(3):203-14. PubMed ID: 9545106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.